This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. It serves as a key intermediate in the creation of drugs targeting central nervous system disorders, such as depression and anxiety, due to its structural compatibility with serotonin and dopamine receptors. Additionally, it has shown potential in the development of treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. Its fluorinated aromatic ring enhances its ability to penetrate the blood-brain barrier, making it valuable in designing bioactive molecules with improved efficacy and selectivity. Researchers also explore its use in asymmetric synthesis, leveraging its chiral properties to produce enantiomerically pure compounds for advanced medicinal chemistry applications.